Mineralys Therapeutics (MLYS) Cash & Current Investments (2022 - 2026)
Mineralys Therapeutics' Cash & Current Investments came in at $661.41 million for Q2 2026, up 103.6% from $324.92 million a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Mineralys Therapeutics' Cash & Current Investments was $656.64 million, up 231.3% from FY2024.
- Cash & Current Investments carries a three-year compound annual growth rate of 81.3% (FY2022 to FY2025).
- Going back by year, Cash & Current Investments was $198.19 million in FY2024 (-16.2%), $236.57 million in FY2023 (+114.8%) and $110.11 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q4 2022.
- Year-over-year, Cash & Current Investments has increased for six consecutive quarters, with growth averaging 67.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2025 (growth of 231.3%), and the weakest in Q4 2024 (a decline of 16.2%).
- Business Quant data shows MLYS's Cash & Current Investments at $646.08 million (Q1 2026), $656.64 million (Q4 2025) and $593.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Mineralys Therapeutics | 1.82 Bn | -742.14 Mn | - | 661.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 661.41 Mn |
| Mar 31, 2026 | 646.08 Mn |
| Dec 31, 2025 | 656.64 Mn |
| Sep 30, 2025 | 593.63 Mn |
| Jun 30, 2025 | 324.92 Mn |
| Mar 31, 2025 | 343.03 Mn |
| Dec 31, 2024 | 198.19 Mn |
| Sep 30, 2024 | 263.60 Mn |
| Jun 30, 2024 | 311.12 Mn |
| Mar 31, 2024 | 338.57 Mn |
| Dec 31, 2023 | 236.57 Mn |
| Sep 30, 2023 | 253.76 Mn |
| Jun 30, 2023 | 261.10 Mn |
| Mar 31, 2023 | 270.64 Mn |
| Dec 31, 2022 | 110.11 Mn |
API Access
Mineralys Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();